Jan Zuna

5.2k total citations
61 papers, 1.1k citations indexed

About

Jan Zuna is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Jan Zuna has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Public Health, Environmental and Occupational Health, 44 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Jan Zuna's work include Acute Lymphoblastic Leukemia research (49 papers), Acute Myeloid Leukemia Research (29 papers) and Chronic Myeloid Leukemia Treatments (25 papers). Jan Zuna is often cited by papers focused on Acute Lymphoblastic Leukemia research (49 papers), Acute Myeloid Leukemia Research (29 papers) and Chronic Myeloid Leukemia Treatments (25 papers). Jan Zuna collaborates with scholars based in Czechia, Germany and Netherlands. Jan Zuna's co-authors include Jan Trka, Jan Starý, Ondřej Hrušák, Markéta Žaliová, Markéta Kalinová, Martina Vašková, Eva Froňková, Jan Stuchlý, Kateřina Mužíková and Petr Sedláček and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Jan Zuna

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Zuna Czechia 21 813 739 316 232 155 61 1.1k
Margit König Austria 19 541 0.7× 667 0.9× 412 1.3× 159 0.7× 150 1.0× 43 1.1k
Lisa J. Russell United Kingdom 16 855 1.1× 716 1.0× 189 0.6× 408 1.8× 99 0.6× 30 1.0k
R Panzer-Grümayer Austria 11 503 0.6× 373 0.5× 243 0.8× 212 0.9× 100 0.6× 13 753
Debbie Payne-Turner United States 6 473 0.6× 423 0.6× 272 0.9× 217 0.9× 119 0.8× 14 770
Silja Röttgers Germany 13 453 0.6× 463 0.6× 199 0.6× 166 0.7× 192 1.2× 14 778
S Raimondi United States 11 437 0.5× 707 1.0× 515 1.6× 150 0.6× 137 0.9× 19 1.1k
Linda Olsson Sweden 14 505 0.6× 409 0.6× 253 0.8× 233 1.0× 95 0.6× 29 815
Cornelia Schlee Germany 17 403 0.5× 455 0.6× 497 1.6× 119 0.5× 131 0.8× 27 960
SP Hunger United States 14 491 0.6× 636 0.9× 491 1.6× 94 0.4× 117 0.8× 21 986
Mary Martineau United Kingdom 13 722 0.9× 622 0.8× 166 0.5× 227 1.0× 120 0.8× 17 949

Countries citing papers authored by Jan Zuna

Since Specialization
Citations

This map shows the geographic impact of Jan Zuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Zuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Zuna more than expected).

Fields of papers citing papers by Jan Zuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Zuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Zuna. The network helps show where Jan Zuna may publish in the future.

Co-authorship network of co-authors of Jan Zuna

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Zuna. A scholar is included among the top collaborators of Jan Zuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Zuna. Jan Zuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svatoň, Michael, Petr Sedláček, Renata Formánková, et al.. (2025). NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk. HemaSphere. 9(4). e70124–e70124. 1 indexed citations
2.
Woodward, E. L., Minjun Yang, Hilda van den Bos, et al.. (2023). Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia. Nature Communications. 14(1). 1658–1658. 8 indexed citations
3.
Žaliová, Markéta, Jan Zuna, Claus Meyer, et al.. (2023). Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study. Leukemia. 38(1). 21–30. 1 indexed citations
4.
Yang, Minjun, E. L. Woodward, Nicolas Duployez, et al.. (2020). 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking. Blood. 136(8). 946–956. 38 indexed citations
5.
Nováková, Michaela, Markéta Žaliová, Karel Fišer, et al.. (2020). <i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 106(8). 2066–2075. 32 indexed citations
6.
Žaliová, Markéta, Eliška Potůčková, Alena Musilová, et al.. (2019). ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity. Haematologica. 104(7). 1407–1416. 31 indexed citations
7.
Potůčková, Eliška, Lucie Šrámková, Jan Starý, et al.. (2018). Two novel fusion genes, AIF1L‐ETV6 and ABL1‐AIF1L, result together with ETV6‐ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin. Genes Chromosomes and Cancer. 57(9). 471–477. 4 indexed citations
8.
Švojgr, Karel, et al.. (2012). The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL. Experimental Hematology. 40(5). 379–385. 7 indexed citations
9.
Delft, Frederik W. van, Sharon W. Horsley, Sue Colman, et al.. (2011). Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 117(23). 6247–6254. 64 indexed citations
10.
Vašková, Martina, Pavla Angelisová, Ester Mejstříková, et al.. (2011). High expression of cytoskeletal protein drebrin in TEL/AML1pos B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody. Leukemia Research. 35(8). 1111–1113. 12 indexed citations
11.
Mejstříková, Ester, Eva Froňková, Tomáš Kalina, et al.. (2010). Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 95(6). 928–935. 42 indexed citations
12.
Žaliová, Markéta, Claus Meyer, Gunnar Cario, et al.. (2010). TEL/AML1‐positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases. Pediatric Blood & Cancer. 56(2). 217–225. 9 indexed citations
13.
Žaliová, Markéta, Eva Froňková, Kateřina Krejčíková, et al.. (2009). Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring. Leukemia. 23(5). 944–951. 26 indexed citations
14.
Zuna, Jan, Hélène Cavé, Cornelia Eckert, et al.. (2007). Childhood secondary ALL after ALL treatment. Leukemia. 21(7). 1431–1435. 18 indexed citations
15.
Zuna, Jan, Ondřej Krejčí, Jozef Madžo, et al.. (2005). TEL/AML1 and immunoreceptor gene rearrangements—which comes first?. Leukemia Research. 29(6). 633–639. 3 indexed citations
16.
Zuna, Jan, Kateřina Mužíková, Anthony M. Ford, et al.. (2003). Pre-natal, Clonal Origin of Acute Lymphoblastic Leukaemia in Triplets. Leukemia & lymphoma. 44(12). 2099–2102. 12 indexed citations
17.
Madžo, Jozef, Jan Zuna, Kateřina Mužíková, et al.. (2002). Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia. Cancer. 97(1). 105–113. 29 indexed citations
18.
Trka, Jan, Jan Zuna, C Haškovec, et al.. (1999). [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].. PubMed. 138(1). 12–7. 6 indexed citations
19.
Zuna, Jan, Ondřej Hrušák, Markéta Kalinová, et al.. (1999). TEL/AML1 positivity in childhood ALL: average or better prognosis?. Leukemia. 13(1). 22–24. 53 indexed citations
20.
Hrušák, Ondřej, et al.. (1998). Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. Leukemia. 12(7). 1064–1070. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margit König Breakdown of academic impact, for papers by Lisa J. Russell Breakdown of academic impact, for papers by R Panzer-Grümayer Breakdown of academic impact, for papers by Debbie Payne-Turner Breakdown of academic impact, for papers by Silja Röttgers Breakdown of academic impact, for papers by S Raimondi Breakdown of academic impact, for papers by Linda Olsson Breakdown of academic impact, for papers by Cornelia Schlee Breakdown of academic impact, for papers by SP Hunger Breakdown of academic impact, for papers by Mary Martineau
Rankless by CCL
2026